Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment

Thyroid

Volumn 21, Issue 12, 2011, Pages 1301-1308

  Soyluk, Ozlem ^a   Boztepe, Harika ^a   Aral, Ferihan ^a   Alagol, Faruk ^a   Özbey, Nese Colak ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; THYROGLOBULIN ANTIBODY;

ABLATION THERAPY; ARTICLE; ASPIRATION BIOPSY; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; THYROID PAPILLARY CARCINOMA; THYROID SURGERY; TUMOR VOLUME; WHOLE BODY SCINTISCANNING;

ADOLESCENT; ADULT; AGED; AUTOANTIBODIES; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; TURKEY; YOUNG ADULT;

EID: 82955186956     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0122     Document Type: Article

References (20)

1. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM; The American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
2. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JWA, Wiersinga W; The European Thyroid Cancer Task Force 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787-803. (Pubitemid 43997716)
3. Elisei R, Schlumberger M, Driedger A, Reiners C, Kloos RT, Sherman SI, Haugen B, Corone C, Molinaro E, Grasso L, Leboulleux S, Rachinsky I, Luster M, Lassmann M, Busaidy NL, Wahl RL, Pacini F, Cho SY, Magner J, Pinchera A, Ladenson PW 2009 Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine remnant ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal. J Clin Endocrinol Metab 94:4171-4179.
4. Pacini F, Ladenson PW, Schlumberger M, Driedger A, Luster M, Kloos RT, Sherman S, Haugen B, Corone C, Molinaro E, Elisei R, Ceccarelli C, Pinchera A, Wahl RL, Leboulleux S, Ricard M, Yoo J, Busaidy NL, Delpassand E, Hanscheid H, Felbinger R, Lassmann M, Reiners C 2006 Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized controlled study. J Clin Endocrinol Metab 91:926-932. (Pubitemid 43357760)
5. Mazzaferri EL, Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Lee S, Davies TF, Arafah BM, Ladenson PW, Pinchera A 2003 A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab 88:1433-1441. (Pubitemid 36623351)
6. Kloos RT 2010 Thyroid cancer recurrence in patients clinically free of disease with undetectable or very low serum thyroglobulin values. J Clin Endocrinol Metab 95:5241-5248.
7. Wittekind C, Compton CC, Greene FL, Sobin LH 2002 TNM residual tumor classification revisited. Cancer 94: 2511-2516. (Pubitemid 34457134)
8. Kloos RT, Mazzaferri EL 2005A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later. J Clin Endocrinol Metab 90:5047-5057. (Pubitemid 41262253)
9. Pelttari H, Välimäki MJ, Lö yttyniemi E, Schalin-Jäntti C 2010 Post-ablative serum thyroglobulin is an independent predictor of recurrence in low-risk differentiated thyroid carcinoma-a 16-yr follow-up study. Eur J Endocrinol 163: 757-763.
10. Pellegriti G, Scollo C, Lumera G, Regalbuto C, Vigneri R, Belfiore A 2004 Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: study of 299 cases. J Clin Endocrinol Metab 89:3713-3720. (Pubitemid 39071462)
11. Thorvaldsson SE, Tulinius H, Björnsson J, Bjarnason O 1992 Latent thyroid carcinoma in Iceland at autopsy. Path Res Pract 188:447-450.
12. Russel JP, Engiles JB, Rothstein JL 2004 Proinflammatory mediators and genetic background in oncogene mediated tumor progression. J Immunol 172:4059-4967.
13. Soyluk O, Selcukbiricik F, Erbil Y, Bozbora A, Kapran Y, Ozbey N 2008 Prognostic factors in patients with papillary thyroid carcinoma. J Endocrinol Invest 31:1032-1037.
14. DeGroot LJ, Kaplan EL, McCormick M, Straus FH 1990 Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424.
15. Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ 1992 Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112:1139-1147. (Pubitemid 23008243)
16. Spriano G, Ruscito P, Pellini R, Appetecchia M, Roselli R 2009 Pattern of regional metastases and prognostic factors in differentiated thyroid carcinoma. Acta Otorhinolaryngol Ital 29:312-316.
17. Larbre H, Schvartz C, Schneider N, Delcourt AC, Maes B, Pochart JM, Vaudrey C 2000 Positive antithyroglobulin antibodies in patients with differentiated thyroid carcinoma. What significance? Ann Endocrinol 61:422-427.
18. Lombardi CP, Bellantone R, De Crea C, Paladino NC, Fadda G, Salvatori M, Raffaelli M 2010 Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases and risk factors for recurrence in a high prevalence of goiter area. World J Surg 34:1214-1221.
19. Kim ES, Lim DJ, Baek KH, Lee JM, Kim MK, Kwon HS, Song KH, Kang M II, Cha BY, Lee KW, Son HY 2010 Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules. Thyroid 20:885-891.
20. Grebe SKG 2010 Thyroglobulin autoantibodies, thyroid nodules, and new insights into some old questions. Thyroid 20:841-842.